Risk factors and predictors of intracranial hemorrhage after mechanical thrombectomy in acute ischemic stroke: insights from the Stroke Thrombectomy and Aneurysm Registry (STAR).


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 16 08 2022
accepted: 02 12 2022
medline: 6 11 2023
pubmed: 2 2 2023
entrez: 1 2 2023
Statut: ppublish

Résumé

Reducing intracranial hemorrhage (ICH) can improve patient outcome in acute ischemic stroke (AIS) intervention. We sought to identify ICH risk factors after AIS thrombectomy. This is a retrospective review of the Stroke Thrombectomy and Aneurysm Registry (STAR) database. All patients who underwent AIS thrombectomy with available ICH data were included. Multivariable regression models were developed to identify predictors of ICH after thrombectomy. Subgroup analyses were performed stratified by symptom status and European Cooperative Acute Stroke Study (ECASS) grade. The study cohort comprised 6860 patients. Any ICH and symptomatic ICH (sICH) occurred in 25% and 7% of patients, respectively. Hemorrhagic infarction 1 (HI1) occurred in 36%, HI2 in 24%, parenchymal hemorrhage 1 (PH1) in 22%, and PH2 in 17% of patients classified by ECASS grade. Intraprocedural complications independently predicted any ICH (OR 3.8083, P<0.0001), PH1 (OR 1.9053, P=0.0195), and PH2 (OR 2.7347, P=0.0004). Race also independently predicted any ICH (black: OR 0.5180, P=0.0017; Hispanic: OR 0.4615, P=0.0148), sICH (non-white: OR 0.4349, P=0.0107), PH1 (non-white: OR 3.1668, P<0.0001), and PH2 (non-white: OR 1.8689, P=0.0176), with white as the reference. Primary mechanical thrombectomy technique also independently predicted ICH. ADAPT (A Direct Aspiration First Pass Technique) was a negative predictor of sICH (OR 0.2501, P<0.0001), with stent retriever as the reference. This study identified ICH risk factors after AIS thrombectomy using real-world data. There was a propensity towards a reduced sICH risk with direct aspiration. Procedural complications and ethnicity were predictors congruent between categories of any ICH, sICH, PH1, and PH2. Further investigation of technique and ethnicity effects on ICH and outcomes after AIS thrombectomy is warranted.

Sections du résumé

BACKGROUND BACKGROUND
Reducing intracranial hemorrhage (ICH) can improve patient outcome in acute ischemic stroke (AIS) intervention. We sought to identify ICH risk factors after AIS thrombectomy.
METHODS METHODS
This is a retrospective review of the Stroke Thrombectomy and Aneurysm Registry (STAR) database. All patients who underwent AIS thrombectomy with available ICH data were included. Multivariable regression models were developed to identify predictors of ICH after thrombectomy. Subgroup analyses were performed stratified by symptom status and European Cooperative Acute Stroke Study (ECASS) grade.
RESULTS RESULTS
The study cohort comprised 6860 patients. Any ICH and symptomatic ICH (sICH) occurred in 25% and 7% of patients, respectively. Hemorrhagic infarction 1 (HI1) occurred in 36%, HI2 in 24%, parenchymal hemorrhage 1 (PH1) in 22%, and PH2 in 17% of patients classified by ECASS grade. Intraprocedural complications independently predicted any ICH (OR 3.8083, P<0.0001), PH1 (OR 1.9053, P=0.0195), and PH2 (OR 2.7347, P=0.0004). Race also independently predicted any ICH (black: OR 0.5180, P=0.0017; Hispanic: OR 0.4615, P=0.0148), sICH (non-white: OR 0.4349, P=0.0107), PH1 (non-white: OR 3.1668, P<0.0001), and PH2 (non-white: OR 1.8689, P=0.0176), with white as the reference. Primary mechanical thrombectomy technique also independently predicted ICH. ADAPT (A Direct Aspiration First Pass Technique) was a negative predictor of sICH (OR 0.2501, P<0.0001), with stent retriever as the reference.
CONCLUSIONS CONCLUSIONS
This study identified ICH risk factors after AIS thrombectomy using real-world data. There was a propensity towards a reduced sICH risk with direct aspiration. Procedural complications and ethnicity were predictors congruent between categories of any ICH, sICH, PH1, and PH2. Further investigation of technique and ethnicity effects on ICH and outcomes after AIS thrombectomy is warranted.

Identifiants

pubmed: 36725360
pii: jnis-2022-019513
doi: 10.1136/jnis-2022-019513
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e312-e322

Investigateurs

Marielle Ernst (M)
Stavropoula Tjoumakaris (S)
M Reid Gooch (M)
Nabeel Herial (N)
Kyle Fargen (K)
Dileep R Yavagal (DR)
Eric C Peterson (EC)
Alex Brehm (A)
Edgar Samaniego (E)
Nitin Goyal (N)
Daniel Alan Hoit (DA)
Violiza Inoa-Acosta (V)
Michael Cawley (M)
Gustavo Pradilla (G)
Brian Howard (B)
João Reis (J)
Jaime Pamplona (J)
Rui Carvalho (R)
Brian Hoh (B)
Ryan Hebert (R)
Louis J Kim (LJ)
Melanie Walker (M)
Russell Cerejo (R)
Giulia Frauenfelder (G)
Francesco Diana (F)
Fernanda Rodriguez-Erazú (F)
Waldo Guerrero (W)
Mehmet Akdol (M)

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: PK, JRM, MM and MRL are members of the editorial board of JNIS.

Auteurs

Natasha Ironside (N)

Neurosurgery, University of Virginia, Charlottesville, Virginia, USA ironsidenatasha@gmail.com.

Ching-Jen Chen (CJ)

Neurosurgery, University of Texas McGovern Medical School, Houston, Texas, USA.

Reda M Chalhoub (RM)

Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Peter Wludyka (P)

Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.

Ryan T Kellogg (RT)

Neurosurgery, University of Virginia, Charlottesville, Virginia, USA.

Sami Al Kasab (S)

Neurology, Medical University of South Carolina, Charleston, South Carolina, USA.

Dale Ding (D)

Neurosurgery, University of Louisville, Louisville, Kentucky, USA.

Ilko Maier (I)

Neurology, University Medicine Goettingen, Goettingen, NS, Germany.

Ansaar Rai (A)

Radiology, West Virginia University Hospitals, Morgantown, West Virginia, USA.

Pascal Jabbour (P)

Neurological surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Joon-Tae Kim (JT)

Chonnam National University Hospital, Gwangju, Gwangju, Korea (the Republic of).

Stacey Q Wolfe (SQ)

Neurosurgery, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.

Robert M Starke (RM)

Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.

Marios-Nikos Psychogios (MN)

Department of Neuroradiology, Clinic of Radiology and Nuclear Medicine, University Hospital Basel, Basel, Switzerland.

Amir Shaban (A)

Neurology, University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, USA.

Adam S Arthur (AS)

Semmes-Murphey Neurologic and Spine Institute, Memphis, Tennessee, USA.

Shinichi Yoshimura (S)

Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Jonathan A Grossberg (JA)

Neurosurgery and Radiology, Emory University School of Medicine, Atlanta, Georgia, USA.

Ali Alawieh (A)

Neurosurgery, Emory University, Atlanta, Georgia, USA.

Isabel Fragata (I)

Neuroradiology, Centro Hospitalar de Lisboa Central, Lisboa, Portugal.

Adam J Polifka (AJ)

Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.

Justin R Mascitelli (JR)

Department of Neurosurgery, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

Joshua W Osbun (JW)

Neurosurgery, Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, USA.

Charles Matouk (C)

Neurosurgery, Yale University, New Haven, Connecticut, USA.

Michael R Levitt (MR)

Neurological Surgery, University of Washington School of Medicine, Seattle, Washington, USA.

Travis M Dumont (TM)

Department of Surgery, Division of Neurosurgery, University of Arizona/Arizona Health Science Center, Tucson, Arizona, USA.

Hugo H Cuellar-Saenz (HH)

Neurosurgery, LSUHSC, Shreveport, Louisiana, USA.

Richard Williamson (R)

Neurology, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.

Daniele G Romano (DG)

Neurordiology, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Salerno, Italy.

Roberto Javier Crosa (RJ)

Endovascular Neurosurgery, Médica Uruguaya, Montevideo, Montevideo, Uruguay.

Benjamin Gory (B)

Department of Diagnostic and Interventional Neuroradiology, CHRU Nancy, Nancy, Lorraine, France.

Maxim Mokin (M)

Neurosurgery, University of South Florida College of Medicine, Tampa, Florida, USA.

Mark Moss (M)

Washington Regional Medical Center, Fayetteville, Arkansas, USA.

Kaustubh Limaye (K)

Indiana University, Bloomington, Indiana, USA.

Peter Kan (P)

Neurosurgery, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.

Alejandro M Spiotta (AM)

Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Min S Park (MS)

Neurosurgery, University of Virginia, Charlottesville, Virginia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH